Last reviewed · How we verify
Tramadol Hydrochloride Plus Acetaminophen — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Tramadol Hydrochloride Plus Acetaminophen (Tramadol Hydrochloride Plus Acetaminophen) — Janssen Korea, Ltd., Korea.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tramadol Hydrochloride Plus Acetaminophen TARGET | Tramadol Hydrochloride Plus Acetaminophen | Janssen Korea, Ltd., Korea | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tramadol Hydrochloride Plus Acetaminophen CI watch — RSS
- Tramadol Hydrochloride Plus Acetaminophen CI watch — Atom
- Tramadol Hydrochloride Plus Acetaminophen CI watch — JSON
- Tramadol Hydrochloride Plus Acetaminophen alone — RSS
Cite this brief
Drug Landscape (2026). Tramadol Hydrochloride Plus Acetaminophen — Competitive Intelligence Brief. https://druglandscape.com/ci/tramadol-hydrochloride-plus-acetaminophen. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab